MedTrace Logo

Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer

NCT04645849 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2020-12-07

No results posted yet for this study

Summary

This study aim to determine kinetic of post treatment recovery/variation of a panel of innate and adaptative immune system cells and molecules.

The results should allow to determine the optimal post treatment immunomonitoring timing and panel to be used for future studies.

Conditions

Interventions

BIOLOGICAL

Immunomonitoring

16 patients will be recruited at the end of treatment: an immunoprofiling analysis will be performed out of a blood sample about 1 month, 5 months and 9 months after treatment. 8 patients will be recruited at diagnosis: a immune profile analysis will be performed before the start of treatment. This will give comparative values for the immune system cells and molecules.

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Leila Gofti-Laroche, PharmD · University Hospital, Grenoble

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2021-08-31
Completion
2021-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645849 on ClinicalTrials.gov